Logo image
Back
Economic Burden of Periprosthetic Joint Infection in the United States
Journal article   Peer reviewed

Economic Burden of Periprosthetic Joint Infection in the United States

Steven M. Kurtz, Edmund Lau, Heather Watson, Jordana K. Schmier and Javad Parvizi
The Journal of arthroplasty, v 27(8), pp 61-65
01 Sep 2012
DOI: https://doi.org/10.1016/j.arth.2012.02.022
PMID: 22554729
Featured in Collection :   UN Sustainable Development Goals @ Drexel

Abstract

Life Sciences & Biomedicine Orthopedics Science & Technology
This study characterizes the patient and clinical factors influencing the economic burden of periprosthetic joint infection (PJI) in the United States. The 2001-2009 Nationwide Inpatient Sample was used to identify total hip and knee arthroplasties using International Classification of Diseases, Ninth Revision, procedure codes. The relative incidence of PJI ranged between 2.0% and 2.4% of total hip arthroplasties and total knee arthroplasties and increased over time. The mean cost to treat hip PJIs was $5965 greater than the mean cost for knee PJIs. The annual cost of infected revisions to US hospitals increased from $320 million to $566 million during the study period and was projected to exceed $1.62 billion by 2020. As the demand for joint arthroplasty is expected to increase substantially over the coming decade, so too will the economic burden of prosthetic infections.

Metrics

6 Record Views
1374 citations in Web of Science
1475 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Industry collaboration
Domestic collaboration
Web of Science research areas
Orthopedics
Logo image